NASDAQ: DMACDiamedica Therapeutics Inc Earnings Dates, Reports, Calls
Diamedica Therapeutics earnings were -$27.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest DMAC earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$7.7M, down 3.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DMAC reported annual earnings of -$24.4M, with 26.1% growth.
DMAC earnings history
Current Revenue
$0.0
Current Earnings
-$27.0M
Current Profit Margin
0%
DMAC Return on Equity
Current Company
-61.3%
Current Industry
-60.2%
Current Market
31.5%
DMAC's Return on Equity (-61.3%)... subscribe to Premium to read more.
High Return on Equity Performance
DMAC undefined
Current Company
-55.5%
Current Industry
-2.5%
DMAC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when DMAC announces earnings.
DMAC undefined
Current Company
-78.86%
Current Industry
5.8%
DMAC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
DMAC vs Biotech Stocks
Diamedica Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.